Tobacco use screening and counseling during physician office visits among adults--National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005-2009
- PMID: 22695462
Tobacco use screening and counseling during physician office visits among adults--National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005-2009
Abstract
Tobacco use continues to be the leading cause of preventable disease and death in the United States; cigarette smoking accounts for approximately 443,000 premature deaths annually. In 2009, the prevalence of smoking among U.S. adults was 20.6% (46 million smokers), with no significant change since 2005 (20.9%). In 2010, approximately 69% of smokers in the United States reported that they wanted to quit smoking. Approximately 44% reported that they tried to quit in the past year for ≥1 day; however, only 4%-7% were successful each year. Tobacco dependence has many features of a chronic disease: most patients do not achieve abstinence after their first attempt to quit, they have periods of relapse, and they often require repeated cessation interventions. At least 70% of smokers visit a physician each year, and other smokers visit other health-care professionals, providing key opportunities for intervention. The 2008 update to the U.S. Public Health Service (PHS) Clinical Practice Guideline: Treating Tobacco Use and Dependence recommends that clinicians and health-care delivery systems consistently identify and document tobacco use status and treat every tobacco user seen in a health-care setting using the 5 A's model: 1) ask about tobacco use, 2) advise tobacco users to quit, 3) assess willingness to make a quit attempt, 4) assist in quit attempt, and 5) arrange for follow-up. The PHS guideline also recommends the following as effective methods for increasing successful cessation attempts: individual, group, and telephone counseling; any of the seven first-line medications for tobacco dependence that are approved by the Food and Drug Administration (FDA); and provision of coverage for these treatments by health-care systems, insurers, and purchasers. However, clinicians and health-care systems often do not screen for and treat tobacco use consistently and effectively.
Similar articles
-
Tobacco Screening and Treatment of Patients With a Psychiatric Diagnosis, 2012-2015.Am J Prev Med. 2019 Nov;57(5):687-694. doi: 10.1016/j.amepre.2019.06.009. Epub 2019 Sep 27. Am J Prev Med. 2019. PMID: 31564608
-
Assessment of compliance with U.S. Public Health Service clinical practice guideline for tobacco by primary care physicians.Harm Reduct J. 2015 Mar 7;12:7. doi: 10.1186/s12954-015-0044-3. Harm Reduct J. 2015. PMID: 25889679 Free PMC article.
-
Health-care Provider Screening and Advice for Smoking Cessation Among Smokers With and Without COPD: 2009-2010 National Adult Tobacco Survey.Chest. 2016 Mar;149(3):676-84. doi: 10.1378/chest.14-2965. Epub 2016 Jan 12. Chest. 2016. PMID: 26291388
-
US public health service clinical practice guideline: treating tobacco use and dependence.Respir Care. 2000 Oct;45(10):1200-62. Respir Care. 2000. PMID: 11054899 Review.
-
Differences in Quit Attempts and Cigarette Smoking Abstinence Between Whites and African Americans in the United States: Literature Review and Results From the International Tobacco Control US Survey.Nicotine Tob Res. 2016 Apr;18 Suppl 1(Suppl 1):S79-87. doi: 10.1093/ntr/ntv228. Nicotine Tob Res. 2016. PMID: 26980868 Free PMC article. Review.
Cited by
-
Assessing efficacy of a web-based smoking cessation tool - QuitAdvisorMD: Protocol for a practice-based, clustered, randomized control trial.Contemp Clin Trials Commun. 2024 Jan 28;38:101253. doi: 10.1016/j.conctc.2023.101253. eCollection 2024 Apr. Contemp Clin Trials Commun. 2024. PMID: 38404651 Free PMC article.
-
Rationale, design, and protocol for a hybrid type 1 effectiveness-implementation trial of a proactive smoking cessation electronic visit for scalable delivery via primary care: the E-STOP trial.BMC Prim Care. 2023 Nov 29;24(1):254. doi: 10.1186/s12875-023-02205-3. BMC Prim Care. 2023. PMID: 38030991 Free PMC article.
-
Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.Addict Neurosci. 2023 Sep;7:100083. doi: 10.1016/j.addicn.2023.100083. Epub 2023 Apr 1. Addict Neurosci. 2023. PMID: 37602286 Free PMC article.
-
Shared Lifestyle-Related Risk Factors of Cardiovascular Disease and Cancer: Evidence for Joint Prevention.ScientificWorldJournal. 2023 Jul 22;2023:2404806. doi: 10.1155/2023/2404806. eCollection 2023. ScientificWorldJournal. 2023. PMID: 37520844 Free PMC article. Review.
-
Addressing Tobacco Use in Underserved Communities Outside of Primary Care: The Need to Tailor Tobacco Cessation Training for Community Health Workers.Int J Environ Res Public Health. 2023 Apr 19;20(8):5574. doi: 10.3390/ijerph20085574. Int J Environ Res Public Health. 2023. PMID: 37107861 Free PMC article.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous